Biomarkers sFlt and PlGF for diagnosis and therapy of pulmonaryhypertension
The present invention relates to the use of biomarkers sFlt and PlGF for diagnosis, early recognition and risk stratification of pulmonary hypertension. Thereby an immunologic test (ELISA) for the determination of blood levels of sFlt and PIGF in patients is preferred.
Further Information: PDF
INNOVECTIS Gesellschaft für Innovations-Dienstleistungen mbH
Phone: +49 (0)69/2561632-0
Contact
Dr. Otmar Schöller
Media Contact
All latest news from the category: Technology Offerings
Newest articles
How Geothermal Energy Shapes Bavaria’s Green Future Through Sustainable Energy
The Bavarian State Ministry of Science and the Arts has extended its funding for the research association “Geothermal Alliance Bavaria,” with the University of Bayreuth (UBT) continuing as a member…
Spintronics memory innovation: A new perpendicular magnetized film
Long gone are the days where all our data could fit on a two-megabyte floppy disk. In today’s information-based society, the increasing volume of information being handled demands that we…
Materials with a ‘twist’ show unexpected electronic behaviour
In the search for new materials that can enable more efficient electronics, scientists are exploring so-called 2-D materials. These are sheets of just one atom thick, that may have all…